Interestingly, DTYMK positively impacted MHC class II molecules (HLA-DP, HLA-DM, HLA-DO, HLA-DQ, HLA-DR) expression in LGG but negatively impacted MHCII expression in LUAD and STAD (Figure 6B). This evidence concerns the gene HLA-DMA and gastric adenocarcinoma.